Y-mAbs Reiterates Guidance
Y-mAbs Reiterates Guidance
Y-mabs 重申指导方针
2024 Financial Guidance
2024 年财务指引
Management reiterates its full year 2024 guidance:
管理层重申其2024年全年指导方针：
- Anticipated total DANYELZA net product revenues of between $95 million and $100 million;
- Anticipated operating expenses of between $115 million and $120 million;
- Anticipated total annual cash burn of between $15 million and $20 million; and
- Cash and cash equivalents anticipated to continue to support operations as currently planned into 2027.
- 预计DANYELZA的总产品净收入在9500万美元至1亿美元之间；
- 预计运营费用在1.15亿美元至1.2亿美元之间；
- 预计每年的现金消耗总额在1500万至2,000万美元之间；以及
- 预计现金和现金等价物将按目前的计划在2027年继续支持运营。